How Finley was paid
$18.8M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Total |
|---|---|---|---|---|---|
| J.D. FinleyChief Executive Officer and Chief Financial Officer | $575,000 | $17,736,572 | $47,385 | $431,300 | $18,790,257 |
| Mitchell Jones, M.D., Ph.D.President and Chief Medical Officer | $440,000 | $14,813,319 | $29,238 | $264,000 | $15,546,557 |
What changed and why
- $18.8MChief Executive Officer total compensation rose to $18,790,257 in 2025 due to large stock and option awards.
- 150%Named executive officers received annual cash bonuses based on achievement of 150% of corporate performance targets.
- $575KBase salaries for 2025 were set at $575,000 for the CEO and $440,000 for the Chief Medical Officer.
- Equity awards generally vest quarterly over three years, subject to continuous service and change in control protections.
Other Palisade Bio proxy statements
- 2025 proxy statement
J.D. Finley paid $813,000 (-36% on the year).
Filed Sep 15, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.